| A–healthy controls (n = 46) | B–graft recipients before transplantation (n = 53) | C–graft recipients after transplantation (n = 53) | p value | ||
---|---|---|---|---|---|---|
 |  |  |  | B vs A | B vs C | C vs A |
Age (years)a | 36.8 (5.3) | 37.0 (8.0) | – | 0.73d |  |  |
BMI a | – | 22.6 (4.0) | 23.4 (4.1) |  | 0.33 |  |
HD duration (months)a | – | 35.7 (28.6) | – |  |  |  |
Creatinine (μmol/L)a | – | 846.0 (221.0) | 141.0 (79.0) |  | <0.001 |  |
GFR (mL/min)b, LH (IU/L) | Â | Â | 57.1 (17.2) | Â | Â | Â |
 mean, (SD) | 3.3 (1.3) | 8.9 (6.5) | 6.7 (5.0) | <0.001 | <0.001 | <0.001 |
 median, (5th – 95th percentile) | 3.1 (1.5–5.8) | 6.3 (3.1–24.8) | 5.1 (2.0–16.4) |  |  |  |
 value > 8 UI/Lc, (%) | 0 (0.0) | 19 (36.5) | 13 (24.5) |  |  |  |
 missing datac, (%) | 1 (2.2) | 1 (1.9) | 0 (0.0) |  |  |  |
FSH (IU/L) | Â | Â | Â | Â | Â | Â |
 mean, (SD) | 3.7 (1.7) | 7.7 (7.6) | 11.3 (8.2) | 0.001 | <0.001 | <0.001 |
 median, (5th–95th percentile) | 3.3 (1.4–7.0) | 4.9 (1.6–27.5) | 9.7 (2.0–29.1) |  |  |  |
 value > 7 UI/Lc, (%) | 1 (2.2) | 19 (35.8) | 34 (65.4) |  |  |  |
 missing datac, (%) | 1 (2.2) | 0 (0.0) | 1 (1.9) |  |  |  |
Testosterone (ng/dL) | Â | Â | Â | Â | Â | Â |
 mean (SD) | 512 (156) | 447 (213) | 398 (151) | 0.12 | 0.12 | <0.001 |
 median (5th–95th percentile) | 522 (261–800) | 432 (171–811) | 371 (190–618) |  |  |  |
 value < 288 ng/dLc, (%) | 2 (5.2) | 12 (22.6) | 13 (24.5) |  |  |  |
 missing datac (%) | 8 (17) | 5 (9.4) | 3 (5.2) |  |  |  |
Inhibin B (pg/mL) | Â | Â | Â | Â | Â | Â |
 mean (SD) | 149 (71) | 145 (102) | 93.6 (79.8) | 0.48 | <0.001 | <0.001 |
 median (5th–95th percentile) | 137 (56–309) | 127 (14–348) | 68 (14–280) |  |  |  |
 value < 80 pg/mLc, (%) | 7 (15.2) | 12 (27.9) | 25 (47.2) |  |  |  |
 missing datac, (%) | 0 (0.0) | 10 (18.9) | 8 (15.1) |  |  |  |